Mycophenolic Acid clinical trials
Also written Mycophenolate Mofetil, Cellcept, Myfortic and Lilly-68618.
How each study uses Mycophenolic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Mycophenolic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 3 May 1995 · CELLCEPT · NDA 050722 (FDA, Drugs@FDA)
- European Union
- 14 Feb 1996 · CellCept · EMEA/H/C/000082 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Studies by the year they started
477 studies that test it; most in 2006 (46)
| Year | Studies |
|---|---|
| 1997 | 3 |
| 1998 | 4 |
| 1999 | 7 |
| 2000 | 12 |
| 2001 | 5 |
| 2002 | 29 |
| 2003 | 23 |
| 2004 | 35 |
| 2005 | 31 |
| 2006 | 46 |
| 2007 | 31 |
| 2008 | 15 |
| 2009 | 30 |
| 2010 | 26 |
| 2011 | 8 |
| 2012 | 13 |
| 2013 | 18 |
| 2014 | 15 |
| 2015 | 16 |
| 2016 | 17 |
| 2017 | 13 |
| 2018 | 8 |
| 2019 | 4 |
| 2020 | 12 |
| 2021 | 10 |
| 2022 | 13 |
| 2023 | 11 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 12 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 117 · Other 364
Fred Hutchinson Cancer Center (38) · Novartis Pharmaceuticals (27) · Novartis (26) · Hoffmann-La Roche (22) · M.D. Anderson Cancer Center (11) · Masonic Cancer Center, University of Minnesota (11) · National Institute of Allergy and Infectious Diseases (NIAID) (10) · Astellas Pharma Inc (7)
Often tested with
Tested in the same studies.
Tacrolimus (114) · Fludarabine (94) · Cyclophosphamide (87) · Cyclosporine (77) · Fludarabine phosphate (47) · Melphalan (29) · Sirolimus (29) · Antilymphocyte Serum (25)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 4 phase 3 studies under way
Mycophenolic Acid is the comparator. A study of two new drugs counts under both.
- 1Adalimumab · Assistance Publique - Hôpitaux de Paris · next primary completion Jun 2027
- 1Secukinumab · Chinese PLA General Hospital · next primary completion May 2028
- 1Methotrexate · Incyte Corporation · next primary completion Jan 2031
- 1Ruxolitinib · Incyte Corporation · next primary completion Jan 2031
Reaching primary completion within a year · 15
Studies that test Mycophenolic Acid.
- Dec 2026Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis CongenitaPhase 2 · Boston Children's Hospital
- Dec 2026Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung DiseasePhase 2 · Centre hospitalier de l'Université de Montréal (CHUM)
- Dec 2026BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)Phase 2 · University of Illinois at Chicago
- Dec 2026Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersPhase 2 · Memorial Sloan Kettering Cancer Center
- Dec 2026Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein PurpuraNot applicable · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Jan 2027The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyPhase 2 · Children's Hospital Medical Center, Cincinnati
- Jan 2027Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft LossNot applicable · Rodolfo Alejandro
- Feb 2027A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)Phase 2 · Memorial Sloan Kettering Cancer Center
- May 2027Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaPhase 2 · City of Hope Medical Center
- May 2027Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA NephropathyPhase 2 · Shaheed Suhrawardy Medical College and Hospital
Studies
Open first, then newest update. How each study uses Mycophenolic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 481
- Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersNot yet recruitingPhase 2National Cancer Institute (NCI)NCT07524530Written as Mycophenolate MofetilHow we know
- A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host DiseaseRecruitingPhase 2M.D. Anderson Cancer CenterNCT06973668Written as Mycophenolate MofetilHow we know
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantRecruitingPhase 1City of Hope Medical CenterNCT06996119Written as Mycophenolate MofetilHow we know
- Mycophenolate After Stem Cell Transplant for Systemic SclerosisNot yet recruitingPhase 2Ottawa Hospital Research InstituteNCT07734012Written as Mycophenolate Mofetil 1000 mg twice dailyHow we know
- Allogeneic Hematopoietic Stem Cell Transplant for GATA2 MutationsRecruitingPhase 2National Cancer Institute (NCI)NCT01861106Written as Mycophenolate mofetil (MMF)How we know
- A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of RecurrenceRecruitingPhase 4Ruijin HospitalNCT06468709Written as Glucocorticoids+MMFHow we know
- Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNot yet recruitingPhase 2Stanford UniversityNCT07634536Written as Mycophenolate mofetil (MMF)How we know
- Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung DiseaseRecruitingPhase 2Centre hospitalier de l'Université de Montréal (CHUM)NCT05785065Written as Mycophenolate MofetilHow we know
- Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor TherapyRecruitingPhase 2Fox Chase Cancer CenterNCT07663422Written as Mycophenolate Mofetil plus prednisoneHow we know
- The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyRecruitingPhase 2Children's Hospital Medical Center, CincinnatiNCT05538208Written as Mycophenolate MofetilHow we know
- Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA NephropathyNot yet recruitingPhase 2Shaheed Suhrawardy Medical College and HospitalNCT07785128Written as Mycophenolate Mofetil (MMF)How we know
- Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and PrednisoloneRecruitingPhase 4Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT07760480Written as Mycophenolate Mofetil (MMF) TreatmentHow we know
- Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRRecruitingPhase 2/3University Hospital, AngersNCT02416388Written as Mycophenolic acid (MPA)How we know
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingPhase 2NYU Langone HealthNCT07138898Written as MycophenolateHow we know
- Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell DiseaseRecruitingPhase 2University of Illinois at ChicagoNCT03121001Written as mycophenolate mofetilHow we know
- Allo HSCT Using RIC and PTCy for Hematological DiseasesRecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT05805605Written as Mycophenolate MofetilHow we know
- Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in ChildrenNot yet recruitingNot applicableNanfang Hospital, Southern Medical UniversityNCT07675291Written as Mycophenolate Mofetil (MMF) TreatmentHow we know
- 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute LeukemiaRecruitingPhase 1/2Fred Hutchinson Cancer CenterNCT03128034Written as Mycophenolate MofetilHow we know
- Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingPhase 4University of California, San FranciscoNCT07352566Written as MycophenolateHow we know
- A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)RecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT05736419Written as Mycophenolate MofetilHow we know
See all 481 studies that test Mycophenolic Acid →
Given beside what is tested · 302 — Mycophenolic Acid is usual care or a partner of the new treatment
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of ImmunityRecruitingPhase 2National Cancer Institute (NCI)NCT04339777Written as Mycophenolate mofetil (MMF)How we know
- Lanoracopan to Prevent Acute GVHD Following Haploidentical Peripheral Blood Stem Cell Transplantation: A Prospective Multicenter Single-Arm Exploratory StudyNot yet recruitingPhase 2The First Affiliated Hospital of Soochow UniversityNCT07926698Written as Mycophenolate mofetil (MMF)How we know
- Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesRecruitingPhase 1/2National Cancer Institute (NCI)NCT05327023Written as Mycophenolate mofetilHow we know
- Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesRecruitingPhase 1/2National Cancer Institute (NCI)NCT04959175Written as Mycophenolate MofetilHow we know
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsRecruitingPhase 2Hoffmann-La RocheNCT05039619Written as Mycophenolate MofetilHow we know
- Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic DiseasesRecruitingPhase 2Fred Hutchinson Cancer CenterNCT06013423Written as Mycophenolate MofetilHow we know
- A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) SyndromeRecruitingPhase 2National Cancer Institute (NCI)NCT05027945Written as Mycophenolate mofetil (MMF)How we know
- Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell TransplantationRecruitingPhase 1National Cancer Institute (NCI)NCT07162038Written as Mycophenolate MofetilHow we know
- A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney TransplantationRecruitingPhase 2/3SanofiNCT07412470Written as mycophenolate mofetilHow we know
- Belatacept in Heart TransplantationRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT06478017Written as Mycophenolate Mofetil/SodiumHow we know
- Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell TransplantationRecruitingPhase 2University of NebraskaNCT06799195Written as Mycophenolate Mofetil (MMF)How we know
- Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell TransplantationRecruitingPhase 1OHSU Knight Cancer InstituteNCT07548983Written as Mycophenolate MofetilHow we know
- CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaRecruitingPhase 1Fred Hutchinson Cancer CenterNCT04375631Written as Mycophenolate MofetilHow we know
- Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAMLRecruitingPhase 1/2Heinrich-Heine University, DuesseldorfNCT05807932Written as Mycophenolate MofetilHow we know
- Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNINot yet recruitingPhase 1/2Peking University People's HospitalNCT07796620Written as MMFHow we know
- CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell TransplantationNot yet recruitingPhase 2Medical College of WisconsinNCT07808112Written as Mycophenolate Mofetil (MMF)How we know
- A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive MedicationsRecruitingPhase 3Bristol-Myers SquibbNCT04877288Written as Mycophenolate MofetilHow we know
- Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary MyelofibrosisRecruitingPhase 2Fred Hutchinson Cancer CenterNCT04370301Written as Mycophenolate MofetilHow we know
- Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell TransplantRecruitingPhase 1/2M.D. Anderson Cancer CenterNCT04022239Written as Mycophenolate MofetilHow we know
- A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT07359859Written as Mycophenolate MofetilHow we know
Showing 20 of 302.
As the comparator · 62 — what is tested is compared with Mycophenolic Acid
- Safety and Efficacy of Secukinumab Versus Mycophenolate Mofetil in Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseRecruitingPhase 3Chinese PLA General HospitalNCT07917247Written as Mycophenolate mofetil (MMF)How we know
- Advancing Transplantation Outcomes in ChildrenRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT06055608Written as Mycophenolate MofetilHow we know
- A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)RecruitingPhase 3Incyte CorporationNCT06615050Written as Mycophenolate mofetil (MMF)How we know
- PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid ExposureNot yet recruitingPhase 2Therakos LLCNCT07619898Written as Mycophenolate Mofetil (MMF)How we know
- Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver CancerEnrolling by invitationPhase 4Baylor Research InstituteNCT02081755Written as MyforticHow we know
- Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host DiseaseRecruitingPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06682169Written as Mycophenolate mofetilHow we know
- Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in KoreaNot yet recruitingPhase 4Chong Kun Dang PharmaceuticalNCT06942156Written as Mycophenolate mofetil Tablet/CapsuleHow we know
- Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic SyndromeRecruitingPhase 2Children's Hospital of Chongqing Medical UniversityNCT05843968Written as Mycophenolate MofetilHow we know
- Treatment FOr Corticosteroid Dependent UveitiSNot yet recruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT06258915Written as Mycophenolate MofetilHow we know
- Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation RecipientsRecruitingPhase 4Lee's Pharmaceutical LimitedNCT06114953Written as Mycophenolate MofetilHow we know
- A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic SyndromeCompletedPhase 3Hoffmann-La RocheNCT05627557Written as MMFHow we know
- Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE ScoreCompletedPhase 3Boston Children's HospitalNCT03386539Written as Mycophenolate MofetilHow we know
- Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine ACompletedPhase 4University Hospital, BordeauxNCT02328963Written as mycophenolic acidHow we know
- MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant RecipientsCompletedPhase 4Chong Kun Dang PharmaceuticalNCT06044493Written as Mycophenolate mofetil Tablet/CapsuleHow we know
- Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant PatientsActive, not recruitingPhase 4Chong Kun Dang PharmaceuticalNCT05193565Written as Mycophenolate mofetilHow we know
- Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus NephritisCompletedPhase 3The University of Hong KongNCT02630628Written as Mycophenolate mofetilHow we know
- A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)CompletedPhase 3Incyte CorporationNCT03112603Written as Mycophenolate mofetil (MMF)How we know
- PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCTCompletedPhase 2St. Petersburg State Pavlov Medical UniversityNCT04669210Written as Mycophenolate MofetilHow we know
- Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell TransplantationCompletedNot applicableZhejiang UniversityNCT04838704Written as Calcineurin Inhibitor+Methotrexate+Mycophenolate mofetilHow we know
- Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive ProtocolTerminatedPhase 4Charite University, Berlin, GermanyNCT00866684Written as MycophenolateHow we know
Showing 20 of 62.
Codes
What other systems call Mycophenolic Acid · ClinicalTrials.gg INT007859
- MeSH (NLM) D009173Mycophenolic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) HU9DX48N0TMYCOPHENOLIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 7145Confirmed FDA, Wikidata
- Wikidata Q420553mycophenolic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C673Mycophenolic AcidOne source FDA
- DrugBank DB01024One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009173 | Mycophenolic Acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | HU9DX48N0T | MYCOPHENOLIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 7145 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420553 | mycophenolic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C673 | Mycophenolic Acid | One source FDA |
| DrugBank | DB01024 | — | One source Wikidata |
Also registered as mycophenolate mofetil (UNII 9242ECW6R0 · RxNorm 68149), mycophenolate mofetil hydrochloride (UNII UXH81S8ZVB · RxNorm 237112) and mycophenolate sodium (UNII WX877SQI1G · RxNorm 408142).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.